What's new in ADA Standards of Care in Diabetes?
ADA Scientific Sessions highlight updated Standards of Care guidelinesUpdates include teplizumab to delay type 1 diabetes onset and early screening for liver disease.
> Read more
News and insights brought to you by the International Diabetes Federation
1 in 3 study participants presented with renal or cardiac damages
The early burden of cardiac and renal disease in type 2 diabetesHeart failure and chronic kidney disease are the first and most frequent manifestations of cardiovascular disease in people with type 2 diabetes and are also associated with increased morbidity and mortality risks.
> Read more